570416-35-2

Basic information

• Product Name: 3-chloro-6-isopropylpyridazine
• Synonyms: 3-chloro-6-isopropylpyridazine;3-Chloro-6-(1-methylethyl)pyridazine;Pyridazine, 3-chloro-6-(1-methylethyl)-
• CAS NO: 570416-35-2
• Molecular Formula: C₇H₉ClN₂
• Molecular Weight: 156.61276
• Mol File: 570416-35-2.mol
• Article Data: 5

Chemical Properties

• Boiling Point: 263℃
• Flash Point: 138℃
• Appearance: /
• Density: 1.135
• Storage Temp.: under inert gas (nitrogen or Argon) at 2-8°C
• CAS DataBase Reference: 3-chloro-6-isopropylpyridazine(CAS DataBase Reference)
• NIST Chemistry Reference: 3-chloro-6-isopropylpyridazine(570416-35-2)
• EPA Substance Registry System: 3-chloro-6-isopropylpyridazine(570416-35-2)

Safety Data

• Hazardous Substances Data: 570416-35-2(Hazardous Substances Data)

Usage

General Description

3-Chloro-6-isopropylpyridazine is a chemical compound with the molecular formula C7H9ClN2. It is a pyridazine derivative, containing a chloro group at position 3 and an isopropyl group at position 6 on the pyridazine ring. 3-chloro-6-isopropylpyridazine has potential uses in the field of pharmaceuticals and agrochemicals due to its biological and pharmacological activities. Its properties and potential applications make it a subject of interest for further research and development.

Upstream product

• 570416-36-3 6-isopropylpyridazin-3(2H)-one 

Downstream Products

• 570416-37-4 6-isopropylpyridazin-3-amine 

Relevant articles and documents

BICYCLIC CGRP RECEPTOR ANTAGONISTS

The present invention is directed to bicyclic compounds which are antagonists of CGRP receptors and useful in the treatment or prevention of diseases in which CGRP is involved, such as migraine. The invention is also directed to pharmaceutical compositions comprising these compounds and the use of these compounds and compositions in the prevention or treatment of such diseases in which CGRP is involved.

BENZAMIDE CGRP RECEPTOR ANTAGONISTS

The present invention is directed to benzamide compounds which are antagonists of CGRP receptors and useful in the treatment or prevention of diseases in which CGRP is involved, such as migraine. The invention is also directed to pharmaceutical compositions comprising these compounds and the use of these compounds and compositions in the prevention or treatment of such diseases in which CGRP is involved.

FUSED HETEROCYCLIC SULFONYLUREA COMPOUND, HERBICIDE CONTAINING THE SAME, AND METHOD OF CONTROLLING WEED WITH THE SAME

The present invention provides a compound represented by the formula: wherein Q represents a fused heterocyclic group, X and Y are the same or different and each represent an optionally halogenated lower alkyl group, an optionally halogenated lower alkoxy group, etc. , or a salt thereof, as well as a herbicide comprising the compound or a salt thereof, which exhibits a significant effect for control of sulfonylurea herbicide-resistant weeds in paddy fields and can reduce the number of active ingredients in a combined preparation and a method of controlling sulfonylurea herbicide-resistant weeds which comprises using the same.